XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 5,282 $ 17,079,885 $ (18,218,962) $ (1,133,795)
Beginning balance, Shares at Dec. 31, 2020 5,282,545        
Stock-based compensation $ 979 3,881,658   3,882,637
Stock-based compensation shares 978,721        
Common stock issued in business acquisitions $ 33,010 67,966,329   67,999,339
Common stock issued in business acquisitions, shares 33,009,382        
Net loss     (4,444,559) (39,581) (4,484,140)
Ending balance, value at Mar. 31, 2021 $ 39,271 88,927,872 (22,663,521) (39,581) 66,264,041
End balance, Shares at Mar. 31, 2021 39,270,648        
Beginning balance, value at Dec. 31, 2021 $ 48,232 106,977,976 (31,888,477) 891 75,138,622
Beginning balance, Shares at Dec. 31, 2021 48,232,076        
Notes payable converted to common stock $ 213 329,787   330,000
Notes payable converted to common stock, Shares 212,903        
Exercise of warrants for the issuance of common stock $ 16 24,984   25,000
Exercise of warrants for the issuance of common stock, shares 16,130        
Stock-based compensation 14,196,876   14,196,876
Financing cost for capital raise (10,000)   (10,000)
Net loss     (16,763,041) 193,856 (16,569,185)
Ending balance, value at Mar. 31, 2022 $ 48,461 $ 120,530,510 $ (48,651,518) $ 194,747 $ 73,111,313
End balance, Shares at Mar. 31, 2022 48,461,109